MedTrace Logo

Obesity Paradox in Non Valvular Atrial Fibrillation Regarding Outcomes: Fact or Fiction

NCT03904329 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2022-08-04

No results posted yet for this study

Summary

Obesity paradox In patient with non valvular atrial fibrillation

Conditions

  • Obesity Paradox

Interventions

DRUG

Oral Anticoagulant

Oral tablets of anti coagulations either warfare or NOACs

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-08-01
Completion
2023-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03904329 on ClinicalTrials.gov